肺动脉高压药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00017664
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Pulmonary Hypertension Drug Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场介绍 肺动脉高压是一种动脉血压升高的身体状态。肺动脉高压药物属于专门用于治疗肺动脉高压的抗高血压药物。此外,这类药物还可以治疗危及生命的疾病,如瑞安氏综合征、心律失常、头痛和心绞痛。 市场动态 由于老年人口的增加和高血压的患病率,肺动脉高压药物市场正在不断发展。此外,以广泛的研究和开发活动为目标的政府举措的不断增加以及意识的提高正在推动市场的增长。 市场范围 《至2031年肺动脉高压药物市场分析》是对医疗保健行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在提供肺动脉高压药物市场概述,并按产品和应用详细进行市场细分。肺动脉高压药物市场预计在预测期内将出现高速增长。该报告提供了肺动脉高压药物市场主要参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分 肺动脉高压药物市场根据产品和应用进行细分。根据产品,市场分为前列环素和前列环素类似物、内皮素受体拮抗剂、磷酸二酯酶 5 抑制剂和可溶性鸟苷酸环化酶刺激剂。根据应用,市场分为早期候选药物和晚期候选药物。

Pulmonary Hypertension Drug Market: Strategic Insights

Pulmonary Hypertension Drug Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc
  • Novartis AG
  • Merck Co Inc
  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • F Hoffmann La Roche AG
  • Teva Pharmaceutical Industries Ltd
  • Vectura Group plc

Regional Overview

Regional And Country Scope
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Segment 1产品
  • 前列环素和前列环素类似物
  • 内皮素受体拮抗剂
  • 磷酸二酯酶-5 抑制剂
  • 可溶性鸟苷酸环化酶刺激剂
Segment2申请
  • 早期药物候选物
  • 后期药物候选物
Segment3地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
该报告提供了行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的肺动脉高压药物市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲和中美洲。每个地区的肺动脉高压药物市场随后按各自的国家和细分市场进行细分。该报告涵盖了对全球18个国家以及该地区当前趋势和机遇的分析和预测。该报告从需求和供应方面分析了影响肺动脉高压药物市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估了北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲影响肺动脉高压药物市场的政治、经济、社会和技术因素后。 市场参与者 该报告涵盖了肺动脉高压药物市场的主要发展,包括有机和无机增长战略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长策略包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对肺动脉高压药物的需求不断增长,预计肺动脉高压药物市场的市场参与者未来将拥有利润丰厚的增长机会。下面提到的是从事肺动脉高压药物市场的少数公司名单。该报告还包括肺动脉高压药物市场主要参与者的概况以及他们的 SWOT 分析和市场策略。此外,该报告还重点关注领先的行业参与者,提供公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。
    • 葛兰素史克公司 • 诺华公司 • 默克公司 • 雅培实验室• 勃林格殷格翰有限公司 • 阿斯利康公司 •  F. 霍夫曼-拉罗氏股份公司 • 梯瓦制药工业有限公司 •  Vectura Group plc • 辉瑞公司
Insight Partner 的专门研究和分析团队由经验丰富的专业人士组成,具有先进的统计专业知识,并在现有研究中提供各种定制选项。

Pulmonary Hypertension Drug Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 前列环素和前列环素类似物
  • 内皮素受体拮抗剂
  • 磷酸二酯酶-5 抑制剂
  • 可溶性鸟苷酸环化酶刺激剂
By 申请
  • 早期药物候选物
  • 后期药物候选物
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Novartis AG
  • Merck Co Inc
  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • F Hoffmann La Roche AG
  • Teva Pharmaceutical Industries Ltd
  • Vectura Group plc
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. GlaxoSmithKline plc
    2. Novartis AG
    3. Merck & Co., Inc.
    4. Abbott Laboratories
    5. Boehringer Ingelheim GmbH
    6. AstraZeneca plc
    7. F. Hoffmann-La Roche AG
    8. Teva Pharmaceutical Industries Ltd.
    9. Vectura Group plc
    10. Pfizer Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Device : READ MORE..